Publications by authors named "Duaa Dhahir Abbas"
Hematol Rep
December 2020
Article Synopsis
- Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL) are both types of mature B cell neoplasms, characterized by an abnormal buildup of B cells in various body areas, and treatment usually includes rituximab with chemotherapy to improve survival.
- A study conducted at Mustansiriyah University involved 20 patients (10 with NHL and 10 with CLL) treated with Zytux™, a new drug, over six months to assess its efficacy and safety.
- Results showed an 85% overall response rate, with Zytux™ being as effective and safer than the standard drug MabThera®, suggesting promising outcomes for this new treatment option in early-stage NHL
